Pfizer’s twice-daily weight loss pill joins a long list of obesity drug flops
Print/DownloadPfizer’s twice-daily version of its experimental weight loss pill has now joined a long list of other scrapped drugs that aimed to treat obesity but came with unintended consequences.
The drugmaker…
Read More
